GlassScriptPhysician profile
Vishal Kirit Patel
NPI 1841687530
$7,154.74
in general payments reported to CMS, 2019-2025
31 companies · $1,523 in 2025
The $1,523 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.48 · 2020: $129 · 2021: $125 · 2022: $40.21 · 2023: $4,339 · 2024: $988 · 2025: $1,523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,398 · Education: $3,017 · Travel and Lodging: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,398.36 |
| Education | $3,017.38 |
| Travel and Lodging | $433.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,684.78 | 2023 | Ion, Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $686.84 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $662.06 | 2020-2025 | Fasenra, Breztri, Airsupra |
| United Therapeutics Corporation | $329.39 | 2023-2025 | Tyvaso, Tyvaso |
| Inspire Medical Systems, INC. | $140.60 | 2023-2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $133.56 | 2024-2025 | Dupixent |
| Genzyme Corporation | $124.07 | 2023-2025 | |
| Biosense Webster, INC. | $106.47 | 2022-2023 | Na, Octaray Mapping Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.26 | 2023-2024 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $93.70 | 2024-2025 | Glassia |
| Viatris Specialty LLC | $93.43 | 2025 | Yupelri |
| Abbott Laboratories | $92.25 | 2023 | Aveir |
| Mylan Specialty L.P. | $87.60 | 2023-2024 | Yupelri |
| Verona Pharma, INC. | $85.13 | 2025 | Ohtuvayre |
| Actelion Pharmaceuticals US, INC. | $81.70 | 2024-2025 | Opsumit |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $80.86 | 2025 | Arikayce |
| Grifols USA, LLC | $70.50 | 2024-2025 | Prolastin-C Liquid |
| Ani Pharmaceuticals, INC. | $69.01 | 2023-2025 | Purified Cortrophin Gel |
| Baxter Healthcare | $62.80 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Volara System |
| Merck Sharp & Dohme LLC | $62.70 | 2025 | Winrevair |
| Vifor Pharma, INC. | $57.10 | 2024-2025 | Zemaira |
| Harmony Biosciences LLC | $45.95 | 2024 | |
| Philips North America LLC | $40.84 | 2023-2025 | Vest Therapy Und |
| Amgen INC. | $35.94 | 2025 | Tezspire |
| Electromed, INC. | $29.15 | 2023-2024 | Smartvest |
| Genentech USA, INC. | $19.73 | 2025 | Xolair |
| Tactile Systems Technology INC | $17.35 | 2025 | Nimbl, Flexitouch Plus |
| Pulmonx Corporation | $17.07 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Mallinckrodt Hospital Products INC. | $16.96 | 2025 | Acthar |
| Paratek Pharmaceuticals, INC. | $15.46 | 2025 | Nuzyra |
| Novo Nordisk INC | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.